PMID- 37349195 OWN - NLM STAT- MEDLINE DCOM- 20231106 LR - 20231110 IS - 1879-1484 (Electronic) IS - 0021-9150 (Linking) VI - 384 DP - 2023 Nov TI - Sex-based differences in outcomes after lower extremity bypass for chronic limb-threatening ischemia. PG - 117157 LID - S0021-9150(23)00233-2 [pii] LID - 10.1016/j.atherosclerosis.2023.06.004 [doi] AB - BACKGROUND AND AIMS: Lower extremity bypass surgery is an effective treatment option for patients with chronic limb-threatening ischemia (CLTI). Recent studies have suggested that sex-based differences may impact patient outcomes following lower extremity revascularization, however, results have been inconsistent. METHODS: In this multicenter analysis, we retrospectively identified all infrainguinal bypass procedures performed for CLTI from 2002 to 2021. Patients were separated into two groups based on sex. Primary outcomes were major limb amputation and reintervention for graft patency. RESULTS: Of 843 bypasses performed over the study period, 347 (41.2%) patients were female. Racial/ethnic distribution and medical comorbidities were similar across sex groups. Surgical indications and operative details were also similar between groups, including conduit type (49.9% autogenous), bypass target (65.4% infrageniculate), and concurrent endarterectomy (38.9%). Female and male patients had similar hospital length of stay (6 days [4-9] vs 6 days [4-9]), hospital readmission (25.6% vs 25.0%), and postoperative complications (p=NS each). Female patients had higher major amputation rates (10.1% vs 6.3%, p=0.04) after one year, whereas reintervention rates were similar between groups (26.2% vs 24.6%, p=NS). After accounting for patient factors, female sex (odds ratio [OR] 1.02 [1.00-1.04]), infrageniculate target (OR 1.02 [1.00-1.04]), and bypass for tissue loss (OR 1.02 [1.00-1.04]) were associated with major amputation after bypass (p<0.05 each). CONCLUSIONS: Female sex is associated with a small but significant increase major amputation after lower extremity bypass surgery for CLTI, despite similar clinical presentation, medical comorbidities, and operative details. These data support the increasingly recognized sex disparities in peripheral arterial disease. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Kim, Young AU - Kim Y AD - Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University, Durham, NC, USA. Electronic address: y.kim@duke.edu. FAU - Weissler, E Hope AU - Weissler EH AD - Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University, Durham, NC, USA. FAU - Long, Chandler A AU - Long CA AD - Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University, Durham, NC, USA. FAU - Williams, Zachary F AU - Williams ZF AD - Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University, Durham, NC, USA. FAU - Dua, Anahita AU - Dua A AD - Division of Vascular and Endovascular Surgery, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. FAU - Southerland, Kevin W AU - Southerland KW AD - Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University, Durham, NC, USA. LA - eng PT - Journal Article PT - Multicenter Study DEP - 20230607 PL - Ireland TA - Atherosclerosis JT - Atherosclerosis JID - 0242543 SB - IM MH - Humans MH - Male MH - Female MH - Chronic Limb-Threatening Ischemia MH - Risk Factors MH - Retrospective Studies MH - Limb Salvage/adverse effects/methods MH - Ischemia/surgery MH - *Peripheral Arterial Disease MH - Treatment Outcome MH - Postoperative Complications/etiology MH - Lower Extremity/surgery MH - *Endovascular Procedures/adverse effects OTO - NOTNLM OT - Chronic limb-threatening ischemia OT - Female sex OT - Peripheral artery disease COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/06/23 01:10 MHDA- 2023/11/06 06:41 CRDT- 2023/06/22 21:54 PHST- 2022/10/31 00:00 [received] PHST- 2023/06/01 00:00 [revised] PHST- 2023/06/02 00:00 [accepted] PHST- 2023/11/06 06:41 [medline] PHST- 2023/06/23 01:10 [pubmed] PHST- 2023/06/22 21:54 [entrez] AID - S0021-9150(23)00233-2 [pii] AID - 10.1016/j.atherosclerosis.2023.06.004 [doi] PST - ppublish SO - Atherosclerosis. 2023 Nov;384:117157. doi: 10.1016/j.atherosclerosis.2023.06.004. Epub 2023 Jun 7.